4.7 Article

Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 215, 期 5, 页码 1449-1462

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20171127

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases [1-ZIA-AI001169]
  2. National Heart, Lung, and Blood Institute (National Institutes of Health)
  3. National Natural Science Foundation of China [81761128009]
  4. Grants-in-Aid for Scientific Research [15K08523] Funding Source: KAKEN
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER

向作者/读者索取更多资源

GATA-binding protein 3 (GATA3) acts as the master transcription factor for type 2 T helper (Th2) cell differentiation and function. However, it is still elusive how GATA3 function is precisely regulated in Th2 cells. Here, we show that the transcription factor B cell lymphoma 11b (Bcl11b), a previously unknown component of GATA3 transcriptional complex, is involved in GATA3-mediated gene regulation. Bcl11b binds to GATA3 through protein-protein interaction, and they colocalize at many important cis-regulatory elements in Th2 cells. The expression of type 2 cytokines, including IL-4, IL-5, and IL-13, is up-regulated in Bcl11b-deficient Th2 cells both in vitro and in vivo; such up-regulation is completely GATA3 dependent. Genome-wide analyses of Bcl11b- and GATA3-regulated genes (from RNA sequencing), cobinding patterns (from chromatin immunoprecipitation sequencing), and Bcl11b-modulated epigenetic modification and gene accessibility suggest that GATA3/Bcl11b complex is involved in limiting Th2 gene expression, as well as in inhibiting non-Th2 gene expression. Thus, Bcl11b controls both GATA3-mediated gene activation and repression in Th2 cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据